← All trials
NCT01084213
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2010
- Primary completion
- Jul 1, 2012
- Completion date
- Oct 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 5354
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- Navrongo Health Research Centre, GhanaCollaborator
- University of LiverpoolOverall official - principal investigator
- University of LondonOverall official - principal investigator
- Medical Research and Training Centre, MaliCollaborator
- University of OuagadougouCollaborator
- Kwame Nkrumah University of Science and TechnologyOverall official - principal investigator
- Medical Research Council, The GambiaCollaborator
- University of LiverpoolCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.